Shijiazhuang Yiling Pharmaceutical Co Ltd Net Asset Quality Index
Shijiazhuang Yiling Pharmaceutical Co Ltd net asset quality index. Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Net Asset Quality Index of 78.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥13.98 Billion minus total liabilities of CN¥3.08 Billion yields net assets of CN¥10.90 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002603 book value for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Net asset quality index of Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025. This chart shows how Shijiazhuang Yiling Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 18 annual periods from 2008 to 2025. As of June 2026, the index stands at 78.0%, representing net assets of CN¥10.90 Billion against total assets of CN¥13.98 Billion CNY. Check Shijiazhuang Yiling Pharmaceutical Co Lt (002603) strategic investment index to assess the company's strategic physical and investment asset allocation.
Shijiazhuang Yiling Pharmaceutical Co Ltd Net Asset Quality Index by Year (2008–2025)
Shijiazhuang Yiling Pharmaceutical Co Ltd net asset quality index by year from 2008 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shijiazhuang Yiling Pharmaceutical Co Ltd from 2008 to 2025, covering 18 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shijiazhuang Yiling Pharmaceutical Co Lt (002603) market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 80.3% | CN¥10.98 Billion | CN¥13.67 Billion | CN¥2.69 Billion | ▲ +3.7 pp |
| 2024 | 76.6% | CN¥10.20 Billion | CN¥13.32 Billion | CN¥3.12 Billion | ▲ +9.2 pp |
| 2023 | 67.4% | CN¥11.44 Billion | CN¥16.98 Billion | CN¥5.54 Billion | ▲ +0.5 pp |
| 2022 | 66.9% | CN¥10.93 Billion | CN¥16.34 Billion | CN¥5.41 Billion | ▼ -3.4 pp |
| 2021 | 70.3% | CN¥9.07 Billion | CN¥12.90 Billion | CN¥3.83 Billion | ▼ -7.2 pp |
| 2020 | 77.5% | CN¥8.92 Billion | CN¥11.51 Billion | CN¥2.58 Billion | ▼ -10.1 pp |
| 2019 | 87.7% | CN¥7.95 Billion | CN¥9.07 Billion | CN¥1.12 Billion | ▼ -0.7 pp |
| 2018 | 88.4% | CN¥7.56 Billion | CN¥8.56 Billion | CN¥993.56 Million | ▼ -1.8 pp |
| 2017 | 90.2% | CN¥7.11 Billion | CN¥7.89 Billion | CN¥775.58 Million | ▲ +4.9 pp |
| 2016 | 85.2% | CN¥5.33 Billion | CN¥6.26 Billion | CN¥925.04 Million | ▲ +0.6 pp |
| 2015 | 84.6% | CN¥4.83 Billion | CN¥5.71 Billion | CN¥879.56 Million | ▼ -2.2 pp |
| 2014 | 86.8% | CN¥4.42 Billion | CN¥5.09 Billion | CN¥671.19 Million | ▼ -4.6 pp |
| 2013 | 91.4% | CN¥4.26 Billion | CN¥4.66 Billion | CN¥399.69 Million | ▼ -0.9 pp |
| 2012 | 92.3% | CN¥3.84 Billion | CN¥4.17 Billion | CN¥320.75 Million | ▲ +4.7 pp |
| 2011 | 87.6% | CN¥3.70 Billion | CN¥4.23 Billion | CN¥523.78 Million | ▲ +26.0 pp |
| 2010 | 61.6% | CN¥1.09 Billion | CN¥1.77 Billion | CN¥680.08 Million | ▲ +9.2 pp |
| 2009 | 52.4% | CN¥790.55 Million | CN¥1.51 Billion | CN¥718.89 Million | ▼ -5.8 pp |
| 2008 | 58.2% | CN¥484.03 Million | CN¥831.91 Million | CN¥347.88 Million | — |